Cabenuva

Generic name: Cabotegravir And Rilpivirine
Dosage form: intramuscular suspension, extended-release (200 mg-300 mg/mL)
Drug class: Antiviral combinations

Usage of Cabenuva

Cabenuva is a once-a-month, combination injection containing Cabotegravir and rilpivirine that may be given as a complete regimen to replace a current HIV-1 treatment regimen in adults and children over the age of 12 who weigh at least 77 pounds (35 kg), so long as they meet certain criteria.

HIV-1 is the virus that can cause acquired immunodeficiency syndrome (AIDS).

Cabenuva is a prescription medicine that is used without any other antiviral medicines to treat HIV. It is not a cure for HIV or AIDS.

Cabenuva side effects

Get emergency medical help if you have signs of an allergic Reaction to Cabenuva such as hives; fever, tiredness, body aches, not feeling well; sores or blisters in your mouth; red or puffy eyes; difficulty breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur within a few minutes after an injection. Tell your caregiver if you feel anxious, warm, light-headed, sweaty, or have stomach pain, or numbness in your mouth.

Call your doctor at once if you have:

  • unusual changes in mood or behavior
  • suicidal thoughts or actions
  • liver problems - loss of appetite, nausea, vomiting, stomach pain (upper right side), itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

    • Common Cabenuva side effects may include:

  • injection site reactions, such as pain, redness, swelling, itching, bruising, warmth, or a hard lump where an injection was given
  • dizziness
  • fever
  • feeling tired
  • headache,
  • nausea
  • pain in your bones, joints, or muscles
  • rash
  • sleep problems.

    • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Cabenuva

    To make sure that the Cabenuva injection kit is safe for you, tell your doctor if you have ever HAD:

  • a skin rash or an allergic reaction after taking medicine that contains cabotegravir or rilpivirine
  • liver disease, including hepatitis B or C
  • mental illness
  • long QT syndrome (in you or a family member).

    • Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

    Children

    Cabenuva is not approved for use by anyone younger than 12 years old or weighing less than 77 pounds (35 kilograms).

    Pregnancy

    There is a lack of information about using Cabenuva during pregnancy and Cabotegravir and rilpivirine can be detected in systemic circulation for up to 12 months or longer after discontinuing the injections. Talk to your doctor if you are intending to become pregnant to discuss the risks versus benefits taking into consideration that HIV can be passed to your baby if the virus is not controlled during pregnancy.

    If you inadvertently become pregnant there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to cabotegravir or rilpivirine during pregnancy. Your healthcare provider can register you by calling the Antiretroviral Pregnancy Registry (APR) at 1-800-258-4263.

    Lactation

    Women with HIV or AIDS should not breastfeed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.

    Relate drugs

    How to use Cabenuva

    Before your doctor administers Cabenuva injections they will need to determine that you can tolerate the active ingredients, which are cabotegravir and rilpivirine. At least 28 days before your first injection, you will take cabotegravir and rilpivirine in tablet forms once per day with a meal. This "lead-in dose" will help determine that you can safely use these medicines together.

  • On the last day you take the tablets, you will receive your first injectable dose of this medicine. Cabenuva is injected into the gluteal (buttock) muscle once a month. A healthcare provider will give you this medicine as 2 separate injections in the SAMe muscle, 2cm apart, or one injection in each buttock.
  • You will be watched closely for about 10 minutes after each injection, to make sure you do not have a serious reaction.
  • The timing of your injections is very important to the success of your HIV treatment. Your doctor may set a calendar day as your "target treatment date" to help keep you on schedule. If needed, you may receive an injection early or late, up to 7 days before or 7 days after your target date.
  • You must remain under the care of a doctor while receiving your injections. Stay on schedule to get the most benefit. Missing doses can increase your risk of medication-resistant HIV.
  • If you stop using Cabenuva, you will need to start using other HIV medicines within 1 month to prevent your condition from becoming resistant. Call your healthcare provider right away to discuss your treatment options.
  • You will need frequent medical tests. Cabenuva can have long-lasting effects on your body (up to 12 months after your last dose). You may still need medical tests for a short time after you stop using this medicine.

    • Warnings

    Should not be given to people with a history of hypersensitivity reactions to cabotegravir or rilpivirine or to any of the iNACtive ingredients in the injection kit.

    Tell your doctor about all your current medicines and any you start or stop using. Many drugs can interact, and some drugs can decrease the effectiveness of Cabenuva and should not be used together.

    Serious injection-related reactions have occurred with the rilpivirine component. Tell your doctor if you experience any severe pain, swelling, or redness at the injection site.

    Adverse liver toxicity has been reported with cabotegravir and rilpivirine injections and your doctor will need to monitor your liver function tests.

    Depression has also been reported. Tell your doctor if you experience any changes in your mood.

    Although residual concentrations of cabotegravir or rilpivirine can remain in your circulation for up to 12 months following your last injections, it is important that if you discontinue Cabenuva or if virological failure is suspected, then a new regimen is initiated no later than 1 month after the final injection.

    What other drugs will affect Cabenuva

    Do not use Cabenuva with other medicines that are used to treat HIV.

    Other medications can affect how the injections work. Examples include:

  • apalUTAmide
  • certain antibiotics - clarithromycin, erythromycin, or rifampin
  • Dexamethasone
  • Enzalutamide
  • medications with a known risk of Torsade de Pointes, such as droperidol or disopyramide
  • methadone
  • seizure medications, such as Carbamazepine, oxcarbazepine, phenobarbital, phenytoin, or primidone
  • St. John's wort
  • Viekira Pak (Ombitasvir, paritaprevir, and ritonavir" href="/drugs/dasabuvir-ombitasvir-paritaprevir-and-ritonavir-3767/">Dasabuvir, ombitasvir, paritaprevir, and ritonavir).

    • Medications that induce uridine diphosphate glucuronosyltransferase (UGT)1A1 or cytochrome P450 (CYP)3A4 may also decrease the plasma concentrations of cabotegravir and rilpivirine.

    Cabenuva can stay in your system for 12 months or longer. If you stop using it, follow your doctor's instructions about using any other medicines during the first year after your last dose.

    This list is not complete. Many other drugs may interact with atorvastatin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

    Popular FAQ

    No, Cabenuva is a long-acting medication given by your healthcare provider as 2 separate injections (cabotegravir and rilpivirine) into your gluteal (buttock) muscles once every month OR once every other month. Cabenuva is used for the treatment of HIV-1 infection in patients 12 years of age and older and weighing at least 35 kg (77 lbs).

    Yes, Cabenuva (cabotegravir and rilpivirine) is a long-acting injection used to treat (but not prevent) HIV-1 infection. Cabotegravir is an antiviral integrase strand transfer inhibitor (INSTI) and rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). These medicines keep HIV from multiplying in your body. The brand name Apretude only contains cabotegravir and is used as a long-acting injection for HIV prevention (PrEP).

    Cabenuva is injected into your buttocks. The Cabenuva injection kit consists of two separate single-dose vials. One vial contains cabotegravir and the other vial contains rilpivirine. The cabotegravir vial is injected into one buttock and the rilpivirine vial is injected into the other buttock.

    The Cabenuva manufacturer is ViiV Healthcare. In the US, call 1-844-588-3288 (toll-free), Monday-Friday, 8AM to 11PM (ET), or contact ViiV online for more information.

    Apretude (cabotegravir) extended-release injection is a long-acting pre-exposure prophylaxis (PrEP) prescription medicine used to prevent HIV infection in people at risk for sexually-acquired HIV exposure. Cabenuva (cabotegravir and rilpivirine) is also a long-acting injection but is used to treat (not prevent) HIV-1 infection. Continue reading

    No, Cabenuva is a long-acting medication given by your healthcare provider as 2 separate injections (cabotegravir and rilpivirine) into your gluteal (buttock) muscles once every month OR once every other month. Cabenuva is used for the treatment of HIV-1 infection in patients 12 years of age and older and weighing at least 35 kg (77 lbs).

    Yes, Cabenuva (cabotegravir and rilpivirine) is a long-acting injection used to treat (but not prevent) HIV-1 infection. Cabotegravir is an antiviral integrase strand transfer inhibitor (INSTI) and rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). These medicines keep HIV from multiplying in your body. The brand name Apretude only contains cabotegravir and is used as a long-acting injection for HIV prevention (PrEP).

    Cabenuva is injected into your buttocks. The Cabenuva injection kit consists of two separate single-dose vials. One vial contains cabotegravir and the other vial contains rilpivirine. The cabotegravir vial is injected into one buttock and the rilpivirine vial is injected into the other buttock.

    The Cabenuva manufacturer is ViiV Healthcare. In the US, call 1-844-588-3288 (toll-free), Monday-Friday, 8AM to 11PM (ET), or contact ViiV online for more information.

    Apretude (cabotegravir) extended-release injection is a long-acting pre-exposure prophylaxis (PrEP) prescription medicine used to prevent HIV infection in people at risk for sexually-acquired HIV exposure. Cabenuva (cabotegravir and rilpivirine) is also a long-acting injection but is used to treat (not prevent) HIV-1 infection. Continue reading

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords